HRP20090134T3 - Tripeptid i tetrapeptid sulfoni - Google Patents

Tripeptid i tetrapeptid sulfoni

Info

Publication number
HRP20090134T3
HRP20090134T3 HR20090134T HRP20090134T HRP20090134T3 HR P20090134 T3 HRP20090134 T3 HR P20090134T3 HR 20090134 T HR20090134 T HR 20090134T HR P20090134 T HRP20090134 T HR P20090134T HR P20090134 T3 HRP20090134 T3 HR P20090134T3
Authority
HR
Croatia
Prior art keywords
optionally substituted
alkyl
tripeptide
ester
compound
Prior art date
Application number
HR20090134T
Other languages
English (en)
Inventor
R. Schow Steven
Aurrecoechea Natalia
Original Assignee
Telik Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc. filed Critical Telik Inc.
Publication of HRP20090134T3 publication Critical patent/HRP20090134T3/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Spoj formulenaznačen time, da: X je L-γ-glutamil, ili L-γ-glutamilglicil; Y je H, po izboru supstituiran alkil, po izboru supstituiran heteroalkil, po izboru supstituiran aril, po izboru supstituiran aralkil, po izboru supstituiran heteroaril, ili po izboru supstituiran heteroaralkil; i Z je C5-9 alkil, po izboru supstituirani aril, po izboru supstituiran aralkil, po izboru supstituirani heteroaralil, ili po izboru supstituirani heteroaralkil; ili njegov C1-10 alkil, fenil-C1-3 alkil, ili (C5-6 heteroaril)-C1-3 alkil mono- ili di-ester; ili sol spoja ili njegov mono- ili di-ester. Patent sadrži još 26 patentnih zahtjeva.
HR20090134T 2005-01-06 2009-03-06 Tripeptid i tetrapeptid sulfoni HRP20090134T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64193205P 2005-01-06 2005-01-06
PCT/US2006/000532 WO2006074409A1 (en) 2005-01-06 2006-01-05 Tripeptide and tetrapeptide sulfones

Publications (1)

Publication Number Publication Date
HRP20090134T3 true HRP20090134T3 (hr) 2009-04-30

Family

ID=36123437

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20090128T HRP20090128T3 (hr) 2005-01-06 2009-03-03 Tripeptid i tetrapeptid tioeteri
HR20090134T HRP20090134T3 (hr) 2005-01-06 2009-03-06 Tripeptid i tetrapeptid sulfoni

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HR20090128T HRP20090128T3 (hr) 2005-01-06 2009-03-03 Tripeptid i tetrapeptid tioeteri

Country Status (25)

Country Link
US (2) US7129215B2 (hr)
EP (2) EP1833978B1 (hr)
JP (2) JP4903716B2 (hr)
KR (2) KR101244609B1 (hr)
CN (2) CN101090977B (hr)
AR (2) AR051889A1 (hr)
AT (2) ATE410520T1 (hr)
AU (2) AU2006204022B2 (hr)
BR (2) BRPI0606520A2 (hr)
CA (2) CA2587284C (hr)
DE (2) DE602006003064D1 (hr)
DK (2) DK1833978T3 (hr)
EA (2) EA200701398A1 (hr)
ES (2) ES2314890T3 (hr)
HK (2) HK1106778A1 (hr)
HR (2) HRP20090128T3 (hr)
IL (2) IL182836A (hr)
MX (2) MX2007008255A (hr)
NZ (2) NZ555362A (hr)
PL (2) PL1833978T3 (hr)
PT (2) PT1833978E (hr)
SI (2) SI1833978T1 (hr)
TW (2) TWI317739B (hr)
WO (2) WO2006074249A1 (hr)
ZA (2) ZA200704487B (hr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198247B2 (en) * 2004-12-21 2012-06-12 Telik, Inc. Process for and intermediates in the preparation of canfosfamide and its salts
KR101244609B1 (ko) * 2005-01-06 2013-03-25 텔리크 인코포레이티드 트리펩티드 및 테트라펩티드 티오에테르
US20070154963A1 (en) * 2005-12-30 2007-07-05 Danying Cai Method to determine whether a compound is a cellular GSTpi inhibitor
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
JP5424887B2 (ja) * 2006-11-08 2014-02-26 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
WO2008149181A1 (en) 2007-06-04 2008-12-11 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
WO2010065936A1 (en) 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
DE102008060888A1 (de) 2008-12-09 2010-06-10 Evonik Stockhausen Gmbh Verfahren zur Herstellung von Acrolein umfassend die Aufarbeitung einer Rohglycerin-Phase
DK2427475T3 (da) 2009-05-08 2021-02-01 Techfields Biochem Co Ltd Prodrug-sammensætninger med høj gennemtrængelighed af peptider og peptid-relaterede forbindelser
JP2013528214A (ja) 2010-06-07 2013-07-08 テリック，インコーポレイテッド 結晶性エザチオスタット塩酸塩非溶媒和物ｄ型の調製
CN102917694A (zh) * 2010-06-07 2013-02-06 泰立克公司 依泽替米贝的片剂制剂
US20130035389A1 (en) * 2011-08-05 2013-02-07 Telik, Inc. Methods for treating myelodysplastic syndrome with ezatiostat
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
CN106146616A (zh) * 2015-04-03 2016-11-23 浙江海正药业股份有限公司 环肽类化合物及其制备和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599903A (en) * 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US5786336A (en) * 1991-04-29 1998-07-28 Terrapin Technologies, Inc. Target-selective protocols based on mimics
US5556942A (en) 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5767086A (en) * 1992-04-03 1998-06-16 Terrapin Technologies, Inc. Bone marrow stimulation by certain glutathione analogs
US5955432A (en) * 1992-04-03 1999-09-21 Terrapin Technologies, Inc. Metabolic effects of certain glutathione analogs
CA2105492C (en) * 1993-09-03 2000-02-01 Lawrence M. Kauvar Glutathione analogs and paralog panels comprising glutathione mimics
US5908919A (en) * 1993-10-01 1999-06-01 Terrapin Technologies Urethane mediated, GST specific molecular release systems
ATE280582T1 (de) * 1995-06-07 2004-11-15 Telik Inc Stoffwechseleffekt von bestimmten glutation analogen
AU4124697A (en) 1996-09-02 1998-03-26 Manchester Metropolitan University, The S-blocked glutathiones
CA2328731A1 (en) * 1998-04-16 1999-10-28 Atsushi Imaizumi Glutathione derivatives and dosage forms thereof
ATE286741T1 (de) * 1999-01-27 2005-01-15 Telik Inc Glutathioneanaloge enthaltende therapeutische zusammensetzungen
US7029695B2 (en) * 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
KR101244609B1 (ko) * 2005-01-06 2013-03-25 텔리크 인코포레이티드 트리펩티드 및 테트라펩티드 티오에테르

Also Published As

Publication number Publication date
ES2314891T3 (es) 2009-03-16
PT1833978E (pt) 2008-12-02
AR051890A1 (es) 2007-02-14
EP1833978B1 (en) 2008-10-08
EP1833842B1 (en) 2008-10-08
KR20070091611A (ko) 2007-09-11
TW200635949A (en) 2006-10-16
BRPI0606520A2 (pt) 2009-06-30
JP2008526859A (ja) 2008-07-24
NZ555361A (en) 2009-05-31
DE602006003063D1 (de) 2008-11-20
AR051889A1 (es) 2007-02-14
EA200701399A1 (ru) 2008-02-28
PL1833978T3 (pl) 2009-04-30
DK1833978T3 (da) 2009-02-09
AU2006204022A1 (en) 2006-07-13
DK1833842T3 (da) 2009-02-09
US7129215B2 (en) 2006-10-31
JP4903717B2 (ja) 2012-03-28
US20060160749A1 (en) 2006-07-20
KR20070104391A (ko) 2007-10-25
ATE410440T1 (de) 2008-10-15
EP1833842A1 (en) 2007-09-19
CN101090977A (zh) 2007-12-19
HRP20090128T3 (hr) 2009-04-30
WO2006074409A9 (en) 2006-12-14
SI1833978T1 (sl) 2009-04-30
ES2314890T3 (es) 2009-03-16
TWI317739B (en) 2009-12-01
MX2007008254A (es) 2007-09-11
PT1833842E (pt) 2008-12-11
EA200701398A1 (ru) 2007-12-28
IL182836A (en) 2010-11-30
KR101244609B1 (ko) 2013-03-25
DE602006003064D1 (en) 2008-11-20
HK1106796A1 (en) 2008-03-20
ZA200704487B (en) 2008-09-25
US7192918B2 (en) 2007-03-20
PL1833842T3 (pl) 2009-04-30
CA2587310A1 (en) 2006-07-13
ZA200704488B (en) 2008-09-25
HK1106778A1 (en) 2008-03-20
IL182836A0 (en) 2007-08-19
ATE410520T1 (de) 2008-10-15
AU2006203901B2 (en) 2011-06-02
AU2006203901A1 (en) 2006-07-13
AU2006204022B2 (en) 2011-01-20
IL183107A (en) 2010-11-30
TWI317738B (en) 2009-12-01
BRPI0606396A2 (pt) 2009-06-23
EP1833978A1 (en) 2007-09-19
CA2587310C (en) 2013-11-12
CN101090977B (zh) 2013-04-10
WO2006074249A1 (en) 2006-07-13
US20060148719A1 (en) 2006-07-06
TW200635948A (en) 2006-10-16
WO2006074409A1 (en) 2006-07-13
SI1833842T1 (sl) 2009-04-30
CA2587284C (en) 2014-03-25
JP4903716B2 (ja) 2012-03-28
MX2007008255A (es) 2007-09-11
NZ555362A (en) 2009-05-31
IL183107A0 (en) 2007-09-20
JP2008526880A (ja) 2008-07-24
CA2587284A1 (en) 2006-07-13
CN101080418A (zh) 2007-11-28

Similar Documents

Publication Publication Date Title
HRP20090134T3 (hr) Tripeptid i tetrapeptid sulfoni
CY1111671T1 (el) Ετεροκυκλικη ενωση
PE20080457A1 (es) Compuestos de oximilo macrociclico inhibidores de proteasas de hepatitis c
HRP20120323T1 (hr) Spoj diaril-hidantoina
AR109135A2 (es) Forma sólida de una sal hidratada de tartrato de un compuesto de pirrolidina inhibidor de dpp-iv
RS52881B (en) BENZAMIDINE COMPOUNDS USED AS HISTONAL DEACETYLASE INHIBITORS
NO20075616L (no) Tripeptider som hepatitt C virus inhibitorer
HRP20100624T8 (hr) Supstituirani pirazolo-piridini, kompozicije koje ih sadrze, postupak za njihovu pripravu, i njihova uporaba
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
RS52534B (en) MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS
EA201070881A1 (ru) Полихромные вещества и их применение
EA200701840A1 (ru) N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
AR057914A1 (es) Compuestos organicos de azufre y su uso
RS51776B (en) MACROCYCLIC HEPATITIS VIRUS INHIBITORS C
HRP20041079B1 (hr) Nova sol perindoprila i farmaceutski pripravci koji je sadrže
JO2585B1 (en) Benzocoinazoline derivatives
ATE529181T1 (de) Neuartiges dispersionsmittel und zusammensetzungen daraus
DE602005025776D1 (de) Mechanische dichtung
WO2008108256A1 (ja) 発光素子材料および発光素子
ATE431827T1 (de) Phosphonocephem-verbindung
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
ATE411287T1 (de) Neue metallproteinaseinhibitoren
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина